Review of Antiplatelet Therapy for the Management of Acute Coronary Syndromes

Dear editor, Currently, cardiovascular diseases are the most common cause of morbidity and mortality in worldwide. Acute coronary syndromes (ACS) form a significant percentage of this disease spectrum. ACS encompasses non-ST-segment elevation myocardial infarction (NSTEMI), STEMI, and unstable angin...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical sciences and health (Online) Vol. 2; no. 3; pp. 34 - 35
Main Author GN, Shivu
Format Journal Article
LanguageEnglish
Published ADICHUNCHANAGIRI INSTITUTE OF MEDICAL SCIENCES 20.10.2016
Subjects
acute coronary syndromes
antiplatelets
Online AccessGet full text

Cover

More Information
Summary:Dear editor, Currently, cardiovascular diseases are the most common cause of morbidity and mortality in worldwide. Acute coronary syndromes (ACS) form a significant percentage of this disease spectrum. ACS encompasses non-ST-segment elevation myocardial infarction (NSTEMI), STEMI, and unstable angina. The basic pathophysiology of ACS comprises plaque rupture with subsequent activation of the coagulation cascade, resulting in thrombus formation, and partial or complete occlusion of the coronary artery. There have been significant improvements in the treatment options and prognosis in ACS patients in the last couple of decades. Antiplatelets play a key role in the management of these patients, and this review focuses on the acute and long- term antiplatelet therapy for ACS patients.
ISSN:2394-9481
2394-949X
DOI:10.46347/JMSH.2016.v02i03.007